Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Angele

Angele Hendrys, New Rochelle, NY US

Patent application numberDescriptionPublished
20100120004SYMBOLTEC - Our subconscious is much smarter than our waking mind but our dreaming mind can be trained to learn a technique (Symboltec) that makes communication between the two accurate, fast and easy. A chart with symbols and a code is all that is needed to ask questions which the dreaming mind answers in its own universal language, that is pictures, which are easy to read. No interpretation is necessary, you just make a note of the picture and decode it.05-13-2010

Angele Sjong, Louisville, CO US

Patent application numberDescriptionPublished
20110114260THERMOPLASTIC COATING AND REMOVAL USING BONDING INTERFACE WITH CATALYTIC NANOPARTICLES - The present disclosure generally describes techniques suitable for use in the construction or recycling of composite materials. An article may comprise a thermoplastic coupled to a bonding interface layer, with a coating layer applied to the surface of the bonding interface layer. A bonding interface layer may comprise catalytic nanoparticles embedded within and/or encapsulated by one or more radiatively unstable polymers. Application of ionizing radiation to the article may release a catalyst at the bonding interface. Application of heat and/or stress to the article may enhance catalytic degradation of the remaining bonding interface and uncoupling of the thermoplastic from the coating layer. Embodiments of methods, compositions, articles and/or systems may be disclosed and claimed.05-19-2011
20110114511APPARATUS FOR DETECTING VOLATILE ORGANIC COMPOUNDS AND RELATED METHODS - Disclosed are apparatuses for detecting one or more volatile organic compounds (VOCs). The apparatuses include a primary electrode and a reference electrode. One or more particles are coupled to the primary electrode and the one or more particles are coupled to one or more enzymes that are capable of undergoing a redox reaction with at least one VOC. The apparatus is configured to measure current or voltage generated between the primary electrode and the reference electrode in response to the redox reaction. The apparatuses can detect a variety of VOCs, including VOCs associated with lung cancer. Also disclosed are biosensor systems including the apparatuses and methods of using the biosensor systems.05-19-2011
20110120884IMPRESSED CURRENT PROTECTION FOR FOOD OR BEVERAGE CONTAINERS - Techniques are generally described herein for protecting food or beverage containers (e.g., cans) using impressed current protection. In various embodiments, containers may be received into at least one conductive bed, each bed having a complementary anode. The containers may then be electrically coupled to a first terminal (e.g., negative) of a power supply, and the anode may be electrically coupled to a second terminal (e.g., positive) of the power supply. Resultantly, protective current may be provided to the containers by the anode. Other embodiments may be disclosed and claimed05-26-2011
20110123860ENCLOSING MANUFACTURE WITH A MAGNESIUM SACRIFICIAL ANODE FOR CORROSION PROTECTION - Techniques generally describe articles of enclosing manufacture and methods related to containers including a magnesium sacrificial anode for corrosion protection. Example articles of enclosing manufacture may include a liner or a rod that is configured as a sacrificial anode to protect a metallic side or end wall of the enclosing manufacture from corrosion. Other embodiments may be disclosed and claimed.05-26-2011

Angele Verot, La Wantzenau FR

Patent application numberDescriptionPublished
20080261215Method for Evaluating the Allergen Sensitivity of an Individual - The present invention discloses a method for evaluating the allergen sensitivity of an individual and/or the clinical efficacy of an allergen immunotherapy comprising the steps: providing at least two samples selected from the group consisting of blood or fractions thereof, connective tissue, nasal, bronchial, skin or gut biopsy material from an individual subjected or intended to be subjected to an immunotherapy with at least one pure allergen or derivative thereof, wherein the samples contain cells capable of releasing mediators in response to said allergen, contacting said sample with said allergen or derivative thereof, and determining the amounts of mediators released from said sample and evaluating the allergen sensitivity of the individual prior to therapy and/or the clinical efficacy of the immunotherapy by comparing said amounts.10-23-2008